Integra LifeSciences Corporation
Nasdaq IART · Princeton, NJ
Works in Cardiovascular · Dermatology · ENT · Immunology · Infectious disease · Metabolic & endocrine · Neurology · Oncology · Renal & urogenital · Respiratory
Integra LifeSciences Corporation is a clinical trial sponsor based in Princeton, NJ, listed as Nasdaq IART. It has 6 active clinical trials with 1,810 planned participants, across 10 therapeutic areas. Since 2021 it has completed 35 trials and stopped 14 early.
Trial track record · since 2021
Financials · Nasdaq IART
Pipeline · 6 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Integra LifeSciences Corporation
Integra LifeSciences Corporation is lead sponsor of 6 active clinical trials on ClinicalTrials.gov, with 1,810 planned participants, in Cardiovascular, Dermatology, ENT, Immunology and other areas. Since 2021 it has completed 35 trials and stopped 14 early.
Integra LifeSciences Corporation is based in Princeton, NJ and is listed as Nasdaq IART. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Integra LifeSciences Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-21.
Approve Suite is not affiliated with Integra LifeSciences Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.